Quinolones in dermatology.
作者信息
Sable David, Murakawa George J
出版信息
Dis Mon. 2004 Jul;50(7):381-94. doi: 10.1016/j.disamonth.2004.05.009.
Abstract
摘要
相似文献
1
Quinolones in dermatology.
Dis Mon. 2004 Jul;50(7):381-94. doi: 10.1016/j.disamonth.2004.05.009.
2
Mutation rate of avian intestinal coliform bacteria when pressured with fluoroquinolones.
Avian Dis. 1998 Jan-Mar;42(1):146-53.
3
Initial clinical experience with clinafloxacin in the treatment of serious infections.克林沙星治疗严重感染的初步临床经验。
Drugs. 1995;49 Suppl 2:488-91. doi: 10.2165/00003495-199500492-00145.
4
[Therapeutic contribution of the new quinolones].[新型喹诺酮类药物的治疗作用]
Rev Prat. 1987 Apr 11;37(21):1209-14.
5
Fluoroquinolone-resistant Salmonella Paratyphi A.耐氟喹诺酮的甲型副伤寒沙门氏菌
Emerg Infect Dis. 2005 Jan;11(1):172-4. doi: 10.3201/eid1101.040145.
6
Fluoroquinolone resistance trends and animal drug use: a retrospective analysis.氟喹诺酮耐药性趋势与兽用药物使用：一项回顾性分析
Int J Infect Dis. 2004 May;8(3):187-9; author reply 190-2. doi: 10.1016/j.ijid.2003.11.006.
7
Resistance of shigella to nalidixic acid & fluorinated quinolones.
Indian J Med Res. 1993 Nov;97:239-41.
8
The rapid development of fluoroquinolone resistance in M. tuberculosis.结核分枝杆菌对氟喹诺酮耐药性的快速发展。
N Engl J Med. 2003 Nov 13;349(20):1977-8. doi: 10.1056/NEJM200311133492023.
9
Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.芦氟沙星（MF - 934）：体内外抗菌活性
Drugs Exp Clin Res. 1989;15(1):11-5.
Zotero 插件